FDA

December 2, 2013
The Food and Drug Administration (FDA) has released a consumer update containing suggestions on how to reduce the amount of acrylamide in one’s diet.  Acrylamide is a chemical found in certain foods that have been fried, toasted or roasted, and has been shown to increase the risk of cancer. Acrylamide forms when starchy foods are cooked at high temperatures for a...
November 6, 2013
Johnson & Johnson (J&J) will pay more than $2.2 billion to resolve criminal and civil liability allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and, payment of kickbacks to physicians and to pharmacy providers, the U.S. Department of...
July 15, 2013
On July 12, 2013, the U.S. Food and Drug Administration (“FDA”) proposed a limit for arsenic in apple juice. The FDA’s proposal comes nearly two years after concerns about the juice were first raised during a segment of “The Dr. Oz Show.” The new proposed standard for arsenic, a carcinogen, is 10 parts per billion (“ppb”).  The...
June 19, 2013
Democrats in Congress, including Senator Richard Blumenthal (D-CT) and Reps. Frank Pallone (D-N.J.) and Rosa DeLauro (D-Conn.), are concerned about the White House Office of Management and Budget’s (OMB) extended delays in clearing the U.S. Food and Drug Administration’s (FDA) proposed guidelines to reduce the amount of arsenic, a known carcinogen, in fruit juice....
March 6, 2013
New Jersey-based Par Pharmaceutical Companies Inc. pleaded guilty in federal court yesterday and agreed to pay $45 million to resolve its criminal and civil liability in the company’s promotion of its prescription drug Megace® ES for uses not approved as safe and effective by the Food and Drug Administration (FDA) and not covered by federal health care programs, the...